These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 6148419

  • 1. Heterocyclic analogues of chlorcyclizine with potent hypolipidemic activity.
    Ashton MJ, Ashford A, Loveless AH, Riddell D, Salmon J, Stevenson GV.
    J Med Chem; 1984 Oct; 27(10):1245-53. PubMed ID: 6148419
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
    Huang Y, Hall IH.
    Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
    [Abstract] [Full Text] [Related]

  • 3. Hypolipidemic activity of rifamycin derivatives.
    Traxler P, Kump W, Mueller K, Tosch W.
    J Med Chem; 1990 Feb; 33(2):552-60. PubMed ID: 2299623
    [Abstract] [Full Text] [Related]

  • 4. Novel pyrimidine and 1,3,5-triazine hypolipidemic agents.
    d'Atri G, Gomarasca P, Resnati G, Tronconi G, Scolastico C, Sirtori CR.
    J Med Chem; 1984 Dec; 27(12):1621-9. PubMed ID: 6502593
    [Abstract] [Full Text] [Related]

  • 5. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds.
    Bondesson G, Hedbom C, Högberg T, Magnusson O, Stjernström NE, Carlson LA.
    J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456
    [No Abstract] [Full Text] [Related]

  • 6. Hypolipidemic activity of substituted 2-pyrrolidinones in rodents.
    Cocolas GH, Chapman JM, Voorstad PJ, Hall IH.
    J Pharm Sci; 1983 Jul; 72(7):812-4. PubMed ID: 6886988
    [Abstract] [Full Text] [Related]

  • 7. Hypolipidemic activity of 6-amino-2-mercapto-5-methyl-pyrimidine-4-carboxylic acid and related derivatives in rodents.
    Hall IH, Cocolas GH, Murthy AR, Rhyne KA, Knowles M.
    J Pharm Sci; 1985 Jul; 74(7):759-64. PubMed ID: 4032250
    [Abstract] [Full Text] [Related]

  • 8. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
    Baggaley KH, Fears R, Hindley RM, Morgan B, Murrell E, Thorne DE.
    J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
    [Abstract] [Full Text] [Related]

  • 9. Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodents.
    Chapman JM, DeLucy P, Wong OT, Hall IH.
    Lipids; 1990 Jul; 25(7):391-7. PubMed ID: 2395418
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T, Takabe S, Maeda S, Matsumoto K, Takashima K, Mori T, Takeyama S.
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [Abstract] [Full Text] [Related]

  • 11. Hypolipidemic activity in rodents of phenobarbital and related derivatives.
    Hall IH, Patrick MA, Maguire JH.
    Arch Pharm (Weinheim); 1990 Sep; 323(9):579-86. PubMed ID: 2288480
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
    Moriya T, Seki M, Takabe S, Matsumoto K, Takashima K, Mori T, Odawara A, Takeyama S.
    J Med Chem; 1988 Jun; 31(6):1197-204. PubMed ID: 3373489
    [Abstract] [Full Text] [Related]

  • 13. Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators.
    Fenton G, Newton CG, Wyman BM, Bagge P, Dron DI, Riddell D, Jones GD.
    J Med Chem; 1989 Jan; 32(1):265-72. PubMed ID: 2909740
    [Abstract] [Full Text] [Related]

  • 14. Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activity.
    Moussavi Z, Depreux P, Lesieur D, Cotelle N, Sauzieres J, Plancke MO, Fruchart JC.
    Farmaco; 1991 Feb; 46(2):339-55. PubMed ID: 1859587
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
    Morishita S, Saito T, Hirai Y, Shoji M, Mishima Y, Kawakami M.
    J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
    [Abstract] [Full Text] [Related]

  • 16. Studies on hypolipidemic agents. II. Synthesis and pharmacological properties of alkylpyrazole derivatives.
    Seki K, Isegawa J, Fukuda M, Ohki M.
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1568-77. PubMed ID: 6467462
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and quantitative structure-activity relationships of antihyperlipaemic 2-substituted thieno[3,2-d]pyrimidin-4(3H)-ones.
    Shishoo CJ, Jain KS, Rathod IS, Thakkar BJ, Brahmbhatt SB, Gandhi TP, Bangaru R, Goyal RK.
    Arzneimittelforschung; 1996 Mar; 46(3):273-6. PubMed ID: 8901148
    [Abstract] [Full Text] [Related]

  • 18. Studies on hypolipidemic agents. II. Synthesis of 1-arenesulfonyloxy-2-alkanone derivatives as potent esterase inhibitors and hypolipidemic agents.
    Ogawa K, Terada T, Muranaka Y, Hamakawa T, Hashimoto S, Fujii S.
    Chem Pharm Bull (Tokyo); 1986 Aug; 34(8):3252-66. PubMed ID: 3791497
    [No Abstract] [Full Text] [Related]

  • 19. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C, Branzoli U, Lovisolo PP, Melloni P, Orsini G, Salvadori P.
    Arzneimittelforschung; 1984 Aug; 34(8):864-9. PubMed ID: 6541922
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: a novel series of PPAR gamma agonists.
    Azukizawa S, Kasai M, Takahashi K, Miike T, Kunishiro K, Kanda M, Mukai C, Shirahase H.
    Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):335-45. PubMed ID: 18310946
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.